<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Debrecen-Hungary_protocols_Ligand_Treatment"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Debrecen-Hungary/protocols/Ligand_Treatment">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Debrecen-Hungary/protocols/Ligand_Treatment&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Debrecen-Hungary/protocols/Ligand_Treatment&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Debrecen-Hungary/protocols/Ligand_Treatment&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Debrecen-Hungary/protocols/Ligand_Treatment" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform">Â </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Debrecen-Hungary/protocols/Ligand Treatment</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2010.igem.org</H3><TABLE><TBODY><TR valign="top" style="margin-right: 0px;"><TD width="1100px" style="padding: 0 0px 0px 0px; background-color:#ede8e2"><DIV class="MenuBar" id="navi"><UL><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/Team" style="color: white"> Team</A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/meetteam"><SPAN><SPAN>Meet the Team</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/gallery"><SPAN><SPAN>Gallery</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/Team#about"><SPAN><SPAN>About The team</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/Team#Lab"><SPAN><SPAN>About The Lab</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/Team#deoec"><SPAN><SPAN>About The University</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/Team#debrecen"><SPAN><SPAN>About  Debrecen</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/Team#cube"><SPAN><SPAN>About  Rubiks's Cube</SPAN></SPAN></A></LI></UL><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/project" style="color: white"> Project</A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/project#abs"><SPAN><SPAN>Abstract</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/project#intro"><SPAN><SPAN>Introduction</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/project#Results"><SPAN><SPAN>Results</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/project#Plans"><SPAN><SPAN>Plans, Possibilities</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/project#BBF_RFC_64_:_Building_Protein_Domain_Based_Composite_Biobricks_for_Mammalian_Expression_Systems"><SPAN><SPAN>RFC 64 suggestion</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/indicontibi"><SPAN><SPAN>Members Contribution</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/parts" style="color: white"> Parts</A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/parts#LBD"><SPAN><SPAN>LBD</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/parts#DBD"><SPAN><SPAN>DBD</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/parts#other"><SPAN><SPAN>Other basic parts</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/parts#composite"><SPAN><SPAN>Composite Parts</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/favorite"><SPAN><SPAN>Favorite Parts</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/protocols" style="color: white"> Protocols</A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/protocols#Contents"><SPAN><SPAN>Cloning Team</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/protocols#Mini_Prep"><SPAN><SPAN>Molecular work team</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/protocols#Gel_electrophoresis"><SPAN><SPAN>Tissue culture team</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/protocols#Measuring_Luciferase_activity_with_the_Victor_plate_reader"><SPAN><SPAN>Luciferase Team</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/sponsors" style="color: white"> Sponsors</A></LI><LI><A style="color: white"> Tools</A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/sitemap"><SPAN><SPAN>Site Map</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/minimals"><SPAN><SPAN>The Minimals</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/safety"><SPAN><SPAN>Safety</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/Team_meetings"><SPAN><SPAN>Team Meetings</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/links"><SPAN><SPAN>Links</SPAN></SPAN></A></LI><LI><A style="color: white"> Side Projects</A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/arsenic"><SPAN><SPAN>Arsenic Project</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/AKG_team"><SPAN><SPAN>AKG team</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/video_project"><SPAN><SPAN>Video Project</SPAN></SPAN></A></LI><LI><A href="https://2010.igem.org/Team:Debrecen-Hungary/on_the_media"><SPAN><SPAN>On The Media</SPAN></SPAN></A></LI></DIV></TD></TR><TR><TD><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1 tocsection-1"><A href="#Scientific_Background"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">Scientific Background</SPAN></A></LI><LI class="toclevel-1 tocsection-2"><A href="#Overview"><SPAN class="tocnumber">2</SPAN><SPAN class="toctext">Overview</SPAN></A></LI><LI class="toclevel-1 tocsection-3"><A href="#Preparation_of_the_ligand_solutions"><SPAN class="tocnumber">3</SPAN><SPAN class="toctext">Preparation of the ligand solutions</SPAN></A></LI><LI class="toclevel-1 tocsection-4"><A href="#Materials"><SPAN class="tocnumber">4</SPAN><SPAN class="toctext">Materials</SPAN></A></LI><LI class="toclevel-1 tocsection-5"><A href="#Procedure"><SPAN class="tocnumber">5</SPAN><SPAN class="toctext">Procedure</SPAN></A></LI><LI class="toclevel-1 tocsection-6"><A href="#Removal_of_the_transfection_medium"><SPAN class="tocnumber">6</SPAN><SPAN class="toctext">Removal of the transfection medium</SPAN></A></LI><LI class="toclevel-1 tocsection-7"><A href="#Materials_2"><SPAN class="tocnumber">7</SPAN><SPAN class="toctext">Materials</SPAN></A></LI><LI class="toclevel-1 tocsection-8"><A href="#Procedure_2"><SPAN class="tocnumber">8</SPAN><SPAN class="toctext">Procedure</SPAN></A></LI><LI class="toclevel-1 tocsection-9"><A href="#Cell_refeeding_with_Ligand-containing_medium"><SPAN class="tocnumber">9</SPAN><SPAN class="toctext">Cell refeeding with Ligand-containing medium</SPAN></A></LI><LI class="toclevel-1 tocsection-10"><A href="#Materials_3"><SPAN class="tocnumber">10</SPAN><SPAN class="toctext">Materials</SPAN></A></LI><LI class="toclevel-1 tocsection-11"><A href="#Procedure_3"><SPAN class="tocnumber">11</SPAN><SPAN class="toctext">Procedure</SPAN></A></LI><LI class="toclevel-1 tocsection-12"><A href="#Notes_.26_troubleshooting"><SPAN class="tocnumber">12</SPAN><SPAN class="toctext">Notes &amp; troubleshooting</SPAN></A></LI><LI class="toclevel-1 tocsection-13"><A href="#References"><SPAN class="tocnumber">13</SPAN><SPAN class="toctext">References</SPAN></A></LI><LI class="toclevel-1 tocsection-14"><A href="#Video"><SPAN class="tocnumber">14</SPAN><SPAN class="toctext">Video</SPAN></A></LI></UL></TD></TR></TBODY></TABLE><H2><SPAN class="mw-headline" id="Scientific_Background">Scientific Background</SPAN></H2><P>Ligand treatment is a procedure when we add the appropriate ligand to the nuclear receptor (NR, transcription factor). The NR got into the cells through a previous transfection step. After treatment the ligand-binded NRs will dimerize and bind to the DNA at specific Nuclear receptor Response Elements and this will promote the gene expression of the downstream gene. In further examinations we detect the expression level of the target gene by Luciferase assay.
</P><H2><SPAN class="mw-headline" id="Overview">Overview</SPAN></H2><P>The target cells in our case are COS1 cells. Performing the protocol from the beginning to the end takes no more than 1 hour, and the following steps are included:
</P><P>1.	Preparation of the ligand solutions
</P><P>2.	Removal of the transfection medium
</P><P>The goal is to get rid of the transfection medium from the COS1 cells 5-7 hours after transfection, because:
</P><P>-	PEI can damage the cells 
</P><P>-	FBS Free medium used for transfection can cause starvation
</P><P>3.	Cell refeeding with Ligand-containing medium
</P><PRE>Our aim is to refeed the cells with 10% FBS containing DMEM and also give appropriate amounts of Ligand in one step.
The 10% FBS in the medium will provide the necessary proteins and other molecules for proliferation and for life
functions. 
The ligand will activate the nuclear receptor and will promote the gene expression.
</PRE><H2><SPAN class="mw-headline" id="Preparation_of_the_ligand_solutions">Preparation of the ligand solutions</SPAN></H2><H2><SPAN class="mw-headline" id="Materials">Materials</SPAN></H2><P>-	Nuclear receptor-transfected cells in a 48-well plate
</P><P>-	10% FBS containing DMEM medium
</P><P>-	Ligand solution in known concentration
</P><P>-	50 ml, 15 ml tubes
</P><P>-	Pasteur pipettes, pipettor, serological pipettes, pipettes, pipet tips
</P><P>-	Sterile laminar air flow box with flame and vacuum system, 37Â°C waterbath, 37Â°C incubator, 70% ethanol squirt bottles
</P><H2><SPAN class="mw-headline" id="Procedure">Procedure</SPAN></H2><P><B>- in the case of 1-type receptor transfection (GAL4PPARg):</B></P><P><I>We use different concentrations of ligand, so as to make a dose-response curve in the subsequent measuring process:</I></P><P><I>10 Î¼M:</I> 200 * (x/10) Î¼L Ligand up to 200Î¼L with 10% DMEM  /per well/
</P><P><I>2 Î¼M:</I> 200 * (x/2) Î¼L Ligand up to 200Î¼L with 10%FBS DMEM  /per well/
</P><P><I>0,4 Î¼M:</I> 200 * (x/0,4) Î¼L Ligand up to 200Î¼L with 10%FBS DMEM  /per well/
</P><P><I>0,08 Î¼M:</I> 200 * (x/0,08) Î¼L Ligand up to 200Î¼L with 10%FBS DMEM  /per well/
</P><P><I>0,016 Î¼M:</I> 200 * (x/0,016) Î¼L Ligand up to 200Î¼L with 10%FBS DMEM  /per well/
</P><P><I>0 Î¼M(negative control):</I> 1 Î¼L DMSO-ethanol(1:1) up to 200Î¼L with 10%FBS DMEM  /per well/
</P><P>if
</P><P>x = original ligand concentartion[mM]
</P><P>we use 48 well plates
</P><P>DMSO-ethanol is the dissolvent of the ligand
</P><P><I>-Prepare the Ligand dilutions:</I></P><P>-	We use 6 wells for 1 concentration / plate
</P><P>-       the total concentration of one well is 200 Î¼L
</P><P>-	For this reason, from 1 concentration we need 6x200=1200 Î¼L
</P><P><I>We are doing serial dilutions (5-fold-dilutions) in 15 ml tubes:</I></P><P>1st dilution (10Î¼M): I calculate with 5000 ul, put 5000*(x/10) Î¼L Ligand solution and fill it up to 5000 Î¼L with 10% FBS containing DMEM. Mix it with pipetting.
</P><P>2nd dilution (2Î¼M): 1 ml from the 1st dilution + 4 ml DMEM 10% 
</P><P>3rd dilution (0,4Î¼M): 1 ml from the 2nd dilution + 4 ml DMEM 10% 
</P><P>4th dilution (0,08Î¼M): 1 ml from the 3rd dilution + 4 ml DMEM 10%
</P><P>5th dilution (0,016Î¼M): 1 ml from the 4th dilution + 4 ml DMEM 10%
</P><P>6th solution (0 Î¼M): 6 Î¼L-ethanol 1:1 solution + 4,994 ml DMEM 10%
</P><UL><LI>you can use serological pipettes and pipettor, or micropipettes with sterile pipette tips.
</LI></UL><UL><LI>these solutions will be enough for three 48-well  plates, if you have less than 3 plates you can store the tubes at +4Â°C and use them next time.
</LI></UL><P><B>- in the case of a 2-type receptor transfection:</B></P><P>The receptor to be activated is Vitamin D Receptor (VDR) and the Ligand is Vitamin D. We use 10e-8 Î¼M Vitamin D. We treat 24 wells only, the other 24 will be negative controls.
</P><P>-Prepare the Vitamin D solution in a 15 ml tube:
</P><P>Fill <I>2000 / (original cc. of the ligand solution [mM]/10e-8)</I> Î¼L ligand solution up to 2000 Î¼L with 10% FBS containing DMEM. Use micropipettes and sterile pipet tips.
</P><H2><SPAN class="mw-headline" id="Removal_of_the_transfection_medium">Removal of the transfection medium</SPAN></H2><H2><SPAN class="mw-headline" id="Materials_2">Materials</SPAN></H2><P>-	Nuclear receptor-transfected cells in a 48-well plate
</P><P>-	Pasteur pipettes 
</P><P>-	Sterile box with flame and vacuum system
</P><H2><SPAN class="mw-headline" id="Procedure_2">Procedure</SPAN></H2><P>Steps:
</P><P>1.	Prepare the hoodÂ : put on your gloves, turn on the ventillation (it needs 15 minutes to filter the air in the box), clean the inner space of the hood with 70% ethanol. Spray hands with ethanol.
</P><P>2.	Place the plate into the hood.Turn on the vacuum system, insert the Pasteur pipette into the vacuum tube. Fire-sterilize the Pasteur pipette.
</P><P>3.	Aspire the used medium from all of the wells, pay attention so as not to aspire the cells (touch only the bottom-side of the wells).
</P><P>4.	Put back the cap of the plate, we donât want the cells to go dry.
</P><H2><SPAN class="mw-headline" id="Cell_refeeding_with_Ligand-containing_medium">Cell refeeding with Ligand-containing medium</SPAN></H2><H2><SPAN class="mw-headline" id="Materials_3">Materials</SPAN></H2><P>-	Ligand solutions prepared in point 1.
</P><P>-	48 well plate without medium (point 2.)
</P><P>-	10% FBS containing medium
</P><P>-	Repeating pipet and tips
</P><P>-	37Â°C incubator, 37Â°C waterbath, Sterile laminar air flow box, 70% ethanol squirt bottles
</P><H2><SPAN class="mw-headline" id="Procedure_3">Procedure</SPAN></H2><P>Steps:
</P><P>1.	Warm up the Ligand solutions for 1- receptor transfected cells and the Ligand solution + 10% FBS DMEM for 2-receptor transfected cells
</P><P>2.	You use the same hood which you prapared: put everything what is needed into the hood after spraying down with 70% alcohol.
</P><P>3.	Take down the cap of the plate. Vortex the Ligand solutions, after that put 
200-200 ul from these solutions into the adequate wells quickly (in other case the cells will go dry). Release the solutions onto the wall of the wells
</P><P>After 1-receptor transfection - by using a 200 Î¼l or a 1 ml pipet with sterile tips
</P><P>10 mM: A1-A3 and E1-E3
</P><P>2 mM: A4-A6 and E4-E6
</P><P>0,4 mM: B1-B3 and F1-F3
</P><P>0,08 mM: B4-B6 and F4-F6
</P><P>0,016 mM: C1-C3 and G1-G3
</P><P>0 mM: C4-C6 and G4-G6
</P><P>After 2-receptor transfection â by using a repeating pipet
</P><UL><LI> Ligand treated /well A1-D6/Â : 200 ul 10e-8 mM Ligand- DMEM solution
</LI></UL><UL><LI> Non-treated /well E1-H6/Â : 200 ul &quot;0 Î¼M&quot; solution
</LI></UL><P>
4.	Put the âtreatedâ COS1 cells into the 37Â°C incubator for 2 days, after 2 days comes the Luciferase assay to make sure that the transfection worked and to measure the Nuclear Receptorâs response to the ligand.
</P><P>5.	Clean the surface
</P><H2><SPAN class="mw-headline" id="Notes_.26_troubleshooting">Notes &amp; troubleshooting</SPAN></H2><H2><SPAN class="mw-headline" id="References">References</SPAN></H2><P>1. Junn Yanagisawa,  Yasuo Yanagi,  Yoshikazu Masuhiro,  Miyuki Suzawa,  Michiko Watanabe,  Kouji Kashiwagi,  Takeshi Toriyabe,  Masahiro Kawabata,  Kohei Miyazono,  Shigeaki Kato  &quot;Convergence of Transforming Growth Factor- and Vitamin D Signaling Pathways on SMAD Transcriptional Coactivators&quot; <A href="http://www.sciencemag.org/cgi/content/abstract/283/5406/1317" class="external text" rel="nofollow">Science 26 February 1999</A></P><H2><SPAN class="mw-headline" id="Video">Video</SPAN></H2><DIV class="printfooter">
Retrieved from &quot;<A href="http://2010.igem.org/Team:Debrecen-Hungary/protocols/Ligand_Treatment">http://2010.igem.org/Team:Debrecen-Hungary/protocols/Ligand_Treatment</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Debrecen-Hungary/protocols/Ligand_Treatment" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Debrecen-Hungary/protocols/Ligand_Treatment" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Debrecen-Hungary/protocols/Ligand_Treatment&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Debrecen-Hungary/protocols/Ligand_Treatment&amp;oldid=167310" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2010.igem.org:Privacy_policy" title="2010.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2010.igem.org:General_disclaimer" title="2010.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>